Interestingly, P-gp overexpression in tumors, including myeloid neoplasms [4,5], enhances drugs extrusion out of cells, reducing chemotherapy efficiency and promoting the phenomenon of resistance to multiple antineoplastic agents [7]. Here, PGP is linked to myeloid neoplasm.